Fibrinolyse dans les AVC

More documents

Recommendations

Info

Davis, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo‐controlled randomised trial. Lancet Neurol 2008
• Phase II • Peu de patients • Vs. placebo • Critères IRM • perfusion/diffusion mismatch > 20% • <strong>AVC</strong> entre 3 et 9h Hacke, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRIbased 9‐hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005
Page 1 and 2: Romain Barthélémy DESC de Réanim
Page 3 and 4: • 333 patients • rt‐PA vs. pl
Page 5 and 6: Wahlgren, et al. Thrombolysis with
Page 7 and 8: Jaillard, et al. Hemorrhagic transf
Page 9 and 10: Patel, et al. Lack of clinical sign
Page 11 and 12: • Comment maîtriser le risque h
Page 13 and 14: ECASS‐III Hacke, et al. Associati
Page 15 and 16: PATIENT CONTRÔLE PATIENT THROMBOLY
Page 17: • Prospective • 74 patients •
Page 21: • Thrombolyse • AVC de moins de

Fibrinolyse dans les AVC

Create successful ePaper yourself

Delete template?

Save as template?